VBLT - Vascular Biogenics Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
46.65M
Enterprise Value 3
4.76M
Trailing P/E
N/A
Forward P/E 1
-2.41
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
77.87
Price/Book (mrq)
1.03
Enterprise Value/Revenue 3
7.95
Enterprise Value/EBITDA 6
-0.25

Trading Information

Stock Price History

Beta (3Y Monthly) 1.84
52-Week Change 3-7.86%
S&P500 52-Week Change 35.71%
52 Week High 31.9000
52 Week Low 30.6000
50-Day Moving Average 31.2474
200-Day Moving Average 31.2839

Share Statistics

Avg Vol (3 month) 323.21k
Avg Vol (10 day) 315.27k
Shares Outstanding 535.88M
Float 22.62M
% Held by Insiders 126.60%
% Held by Institutions 132.18%
Shares Short (Sep 30, 2019) 459.06k
Short Ratio (Sep 30, 2019) 43.7
Short % of Float (Sep 30, 2019) 40.23%
Short % of Shares Outstanding (Sep 30, 2019) 40.16%
Shares Short (prior month Aug 30, 2019) 469.52k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-3,450.08%

Management Effectiveness

Return on Assets (ttm)-20.35%
Return on Equity (ttm)-33.97%

Income Statement

Revenue (ttm)599k
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)-23.30%
Gross Profit (ttm)350k
EBITDA -19.18M
Net Income Avi to Common (ttm)-18.1M
Diluted EPS (ttm)-0.5040
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)45.14M
Total Cash Per Share (mrq)1.26
Total Debt (mrq)3.25M
Total Debt/Equity (mrq)7.15
Current Ratio (mrq)6.45
Book Value Per Share (mrq)1.27

Cash Flow Statement

Operating Cash Flow (ttm)-12.63M
Levered Free Cash Flow (ttm)-8.15M